TY  - JOUR
A1  - Islombek, Sobirjonov
ID  - arxiv63147
UR  - https://mjstjournal.com/index.php/mjst/article/view/5402
Y1  - 2025/10/29/
KW  - peptic ulcer
KW  -  H? receptor blockers
KW  -  cimetidine
KW  -  ranitidine
KW  -  gastric acid secretion
KW  -  histamine antagonists.
AV  - none
JF  - Multidisciplinary Journal of Science and Technology
N1  - Imported from MJST Journal (OAI id oai:ojs.pkp.sfu.ca:article/5402)
TI  - SPECIFICITY OF TREATMENT OF PEPTIC ULCER DISEASE WITH H2 HISTAMINE BLOCKER DRUGS
PB  - Center for Tech and Media Research
N2  - Peptic ulcer disease (PUD) is a chronic condition characterized by mucosal erosion in the stomach or duodenum, resulting from an imbalance between aggressive gastric factors such as acid and pepsin, and defensive mechanisms including mucosal protection, prostaglandin secretion, and epithelial regeneration. Among the major therapeutic milestones in its treatment is the introduction of H? histamine receptor antagonists (H? blockers), which revolutionized gastroenterology by suppressing acid secretion effectively and promoting mucosal healing. This paper discusses the pharmacodynamics, pharmacokinetics, therapeutic specificity, and clinical implications of H? blockers such as cimetidine, ranitidine, famotidine, and nizatidine in the management of peptic ulcer disease. Emphasis is placed on their mechanism of action, comparative efficacy, drug interactions, side effects, and their role in the contemporary era of proton pump inhibitors (PPIs).
ER  -